Advanced search
Publication Cover
Journal of American College Health Volume 63, 2015 - Issue 2
Submit an article Journal homepage
944
Views
11
CrossRef citations to date
0
Altmetric
Brief Report

Sex Differences Among College Students in Awareness of the Human Papillomavirus Vaccine and Vaccine Options

Sarah C. BeshersHealth Department, State University of New York at Cortland, Cortland, New York
, PhD,
Jill M. MurphyHealth Department, State University of New York at Cortland, Cortland, New York
, PhD,
Brian V. FixDepartment of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York
, MA &
Martin C. MahoneyDepartment of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York;Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York
, MD , PhD
Pages 144-147 | Received 20 Feb 2014, Accepted 21 Sep 2014, Published online: 20 Jan 2015

REFERENCES

  • Mahoney MC. Protecting our patients from HPV and HPV-related diseases: the role of vaccines. J Fam Pract. 2006; ( Nov suppl):10–17.
  • Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mort Wkly Rep. 2010;59:626–629.
  • Schwartz JL. HPV vaccination's second act: promotion, competition, and compulsion. Am J Public Health. 2010;100:1841–1844.
  • Hull S, Caplan A. Genital warts: mountains or molehills? Lancet Infect Dis. 2008;8:277–278.
  • Mortensen GL, Larsen HK. The quality of life of patients with genital warts: a qualitative study. BMC Public Health. 2010;10:113.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–4301.
  • Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sex Transm Infect. 2011; 87:52–57.
  • Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health. 2008;57:23–31.
  • DrugAnalyst Ltd. DrugAnalyst Consensus Database. Available at: http://consensus.druganalyst.com/. Accessed December 18, 2014.
  • Chatterjee A. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon. Expert Rev Vaccines. 2014; 13:1279–1290. doi: 10.1586/14760584.2014.963561.
  • Williams WW, Peng-Jun L, Greby S, et al. Noninfluenza vaccination coverage among adults—United States, 2011. MMWR Morb Mort Wkly Rep. 2013;62:66–72.
  • Williams WW, Lu PJ, O'Halloran A, et al. Noninfluenza vaccination coverage among adults — United States, 2012. MMWR Morb Mort Wkly Rep. 2014; 63;95–102.
  • Stokley S, Jeyarajah J, Yankey D, et al. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014—United States. MMWR Morb Mort Wkly Rep. 2014;63:620–624.
  • Elam-Evans L, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR Morb Mort Wkly Rep. 2014;63:625–633.
  • Romanowski B, Schwarz TF, Ferguson LF, et al. Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study. Hum Vaccines Immunother. 2014;10:1155–1165.
  • Dobson, SR, McNeil, S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013;309:1793–1802.
  • Safaeian M, Porras, C, Pan, Y, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res. 2013;6:1242–1250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.